Suicide: The public health crisis of our time

Australian and New Zealand Journal of Medicine

Volumn 28, Issue 3, 1998, Pages 295-300

  Singh, B S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OCCUPATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIAL ASPECT; SOCIOECONOMICS; SUICIDE;

EID: 0031829718     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1998.tb01951.x     Document Type: Review

References (32)

1. Hassan R. Suicide explained: the Australian experience. Melbourne: Melbourne University Press, 1995.
2. Shaffer D, Piacentius J. Suicide and attempted suicide. In: Rutter M, Taylor E, Hersov L (Eds). Child and adolescent psychiatry: Modern approaches. Oxford: Blackwell Scientific Publications, 1994.
3. McClure CMG. Suicide in England and Wales 1975-84. Br J Psychiatry 1987; 150: 309-14.
4. Pritchard C. Youth suicide and gender in Australia and New Zealand compared with countries of the western world 1973-1987. Aust NZ J Psychiatry 1992; 26: 609-17.
5. Kolmos L. Suicide in Scandinavia: An epidemiological analysis. Acta Psychiatr Scand (Suppl.) 1987; 336: 11-16.
6. Mann JJ, Arango V. Integration of neurobiology and psychopathology in a unified model of suicidal behaviour. J Clin Psychopharmacol 1992; 12: 2S-7S.
7. Roy A, Segal NL, Centrewall BS, Robinette CD. Suicide in twins. Arch Gen Psychiatry 1991; 48: 29-32.
8. Brown GL, Ebert MH, Goyer PF et al. Aggression, suicide and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 1982; 139: 741-6.
9. Mann JJ, Underwood MD, Arango V. Postmortem studies of suicide victims. In: Watson SJ (Ed). Biology of Schizophrenia and Affective Disease. Washington DC: American Psychiatric Press, 1996: 197-220.
10. 2 and B-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990; 47: 1038-47.
11. Mann JJ, Malone KM, Sweeney JA et al. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 1996; 15: 576-86.
12. Virkkunen M, De Jong J, Bartko J, Linnoila M. Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Arch Gen Psychiatry 1989; 46: 604-6.
13. Mann JJ, McBride PA, Malone KM, DeMeo MD, Kelip J. Blunted serotonergic responsivity in depressed patients. Neuropsychopharmacology 1995; 13: 53-64.
14. Dorpat TL, Ripley HS. A study of suicide in the Seattle area. Comp Psychiatry 1960; 1: 349-59.
15. Robins E, Murphy G, Wilkinson R et al. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. Am J Public Health 1959; 49: 888-99.
16. Weissman MM, Bland RC, Canino GJ et al. Cross national epidemiology of major depression and bipolar disorder. JAMA 1996; 276: 293-9.
17. Robins LN, Reiger DA (Eds). Psychiatric disorders in America: The Epidemiologic Catchment Area Study. New York: The Free Press, 1991.
18. Tiller J, Krupinski J, Burrows G, Mackenzie A, Hallenstein H, Johnstone G. A prospective study of completed and attempted youth suicides. Melbourne: The University of Melbourne, 1997.
19. Patton GC, Harris R, Carlin JB et al. Adolescent suicide behaviours: a population-based study of risk. Psychol Medicine 1997; 27: 715-24.
20. World Health Organization. Guidelines for the primary prevention of mental, neurological and psychosocial disorders. Geneva: WHO, 1993.
21. Lester D. The effectiveness of suicide prevention centers. Suicide and Life Threatening Behaviour 1993; 23: 263-7.
22. Motto J, Heilbron D, Juster R, Bostrom A. Communication as a suicide prevention programme. In: Soubrier JP, Vedrinne J (Eds). Depression et Suicide. Paris: Pergamon Press, 1981: 148-54.
23. Morgan HG, Jones EM, Owens JH. Secondary prevention of non-fatal deliberate self-harm. Br J Psychiatry 1993; 163: 111-2.
24. Salkovis P, Atha C, Storer D. Cognitive behavioural problem solving in the treatment of patients who repeatedly attempt suicide, a controlled trial. Br J Psychiatry 19??; 157: 871-6.
25. Goldney RD, Smith S, Winefield AH, Tiggermann M, Winefield HR. Suicide ideation: its enduring nature and associated morbidity. Acta Psychiatrica Scandanavica 1991;83:115-20.
26. Isacsson G, Boethius G, Bergma U. Low level of anti-depressant therapy for people who later commit suicide: 15 years of experience from a population based drug data base in Sweden. Acta Psychiatrica Scandanavica 1992; 85: 444-8.
27. Marzuk PM, Tardiff K, Leon A et al. Use of prescription psychotropic drugs among suicide victims in New York city. Am J Psychiatry 1995; 152: 1520-2.
28. Rutz W, von Knorring L, Walinder J. Long term effects of an education program for general practitioners given by the Swedish Committee for the prevention and treatment of depression. Acta Psychiatrica Scandanavica 1992; 85: 83-8.
29. Meltzer HY, Okayli G. Reduction of suicidality using clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk benefit assessment. Am J Psychiatry 1995; 152: 183-90.
30. Coppen A, Standish-Barry H, Bailey J et al. Long term lithium and mortality. Lancet 1990; 335: 1347.
31. Ahrens B, Muller-Oerlinghausen B, Graf F. Length of Lithium treatment needed to eliminate the high mortality of affective disorders. Br J Psychiatry 1993; 163 (Suppl. 21): 27-9.
32. Commonwealth Department of Human Services and Health. Better health outcomes for Australians. National goals, targets and strategies for better health outcomes into the next century. Canberra: Australian Government Printing Service, 1994.